SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001387131-19-006228
Filing Date
2019-08-16
Accepted
2019-08-16 17:02:00
Documents
9
Effectiveness Date
2019-08-16

Document Format Files

Seq Description Document Type Size
1 INITIAL REGISTRATION STATEMENT nbse-s8_081519.htm S-8 109983
2 FORM OF OPTION AGREEMENT UNDER THE OHR PHARMACEUTICAL, INC. 2019 STOCK INCENTIVE ex4-6.htm EX-4.6 129748
3 FORM OF OPTION AGREEMENT UNDER THE NEUBASE THERAPEUTICS, INC. 2018 EQUITY INCENT ex4-8.htm EX-4.8 84568
4 FORM OF COMMON STOCK CERTIFICATE ex4-17.htm EX-4.17 22592
5 OPINION OF PAUL HASTINGS LLP ex5-1.htm EX-5.1 26079
6 CONSENT OF MALONEBAILEY, LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23-1.htm EX-23.1 3844
7 GRAPHIC ex4-17_img001.gif GRAPHIC 4087
8 GRAPHIC ex5-1_img001.jpg GRAPHIC 13963
9 GRAPHIC ex5-1_img002.jpg GRAPHIC 14760
  Complete submission text file 0001387131-19-006228.txt   412891
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-233346 | Film No.: 191034094
SIC: 2834 Pharmaceutical Preparations